Experienced Biopharmaceutical Executive Steve Glover Joins Insmed Incorporated; Will Lead Development of Follow-on Biologics

RICHMOND, Va.--(BUSINESS WIRE)--Insmed Inc. (Nasdaq:INSM) today announced that Steve Glover, 48, has joined Insmed’s management team as President of the newly formed Follow-on Biologics business, effective June 22, 2007. Mr. Glover will be responsible for leading the development of Insmed’s follow-on biologics capability and its emerging portfolio of biogeneric/biosimilar products.
MORE ON THIS TOPIC